Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A recent Japanese study found that this risk reduction was greater than that associated with the hep B vaccine.
A recent study found one in five people with HIV should be assessed for fatty liver, and 1 in 10 should be referred to a liver specialist.
A triple regimen of Opdivo, Yervoy and Cabometyx showed good activity, but side effects may limit its use.
This finding may reflect higher rates of sexually transmitted infections such as HPV and hep B as well as lifestyle factors.
A scientific platform that acts as a catalyst to accelerate the progress for achieving a cure.
Chinese researchers studied 81 women with chronic hepatitis B who began taking Viread before pregnancy.
There are 5 viruses that cause viral hepatitis. A look at hepatitis A, B, C, D, and E.
Researchers analyzed more than 350 studies to estimate the prevalence of hepatitis B among people with HIV around the world.
The LIVER Act would increase funding for liver cancer and hepatitis B research and prevention.
Researchers have called for revised treatment guidelines to address the higher risk of fracture in the HIV population.
A recent study of more than 1,000 veterans found that nearly 1% had hepatitis B and 14% had been exposed to the virus.
The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.
People who receive chemotherapy for cancer have a higher risk of hep B reactivation.
Lonafarnib and bulevirtide, when used with pegylated interferon, reduced hepatitis delta levels in two studies.
Experts are not certain what this latest trend signifies for the trajectory of the opioid use disorder epidemic, however.
Normalizing ALT liver enzyme levels is associated with positive long-term outcomes.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.